Optical Blood Glucose Sensor Using Light Collection System

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current non-invasive blood glucose monitoring devices face challenges in accurately measuring glucose levels due to interference from skin, fat, muscle, bone, and interstitial fluid, resulting in high baseline noise and low signal-to-noise ratios, which limits the detection of the small cyclic pattern of light absorption by blood.

Innovation Solution

The use of a light collection system with a light illumination funnel and an aspheric lens to increase light power and improve signal-to-noise ratios, including a processor to calculate the change in light absorption caused by blood using multiple light beams of different wavelengths and interference filters to focus and concentrate light onto a detector array.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If non-invasive optical spectroscopy is used to measure blood glucose, then the pain and inconvenience of blood sampling is eliminated, but the measurement accuracy deteriorates due to interference from skin, fat, muscle, bone, and interstitial fluid

Engineering Contradiction:
Improvenon-invasive measurementVSAvoidglucose concentration accuracy
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The optical spectrum is segmented into multiple wavelength regions, with specific emphasis on the 900-1100 nm range where blood absorbs light differently than other tissues. By analyzing specific spectral segments rather than the entire spectrum, the device can isolate blood-related absorption patterns from interference by skin, fat, muscle, and bone.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent applies local quality by using wavelength-specific detection where different wavelengths are optimized for different penetration depths and tissue types. The 900-1100 nm range provides optimal local quality for blood glucose detection because this spectral region exhibits characteristic absorption by hemoglobin and glucose while minimizing absorption by other tissues.

Inventive Principle:
Principle #3Local quality

2Ease of operation

If the detection area includes all body tissues (skin, fat, muscle, bone, blood), then non-invasive measurement is achieved, but the signal-to-noise ratio deteriorates due to overwhelming background absorption from non-blood tissues

Engineering Contradiction:
Improvenon-invasive accessVSAvoidsignal-to-noise ratio
Core Design Contradiction:
Ease of operationVSLoss of information

Solution Approach 1:

The patent extracts the useful blood-related signal from the total optical absorption by using wavelength regions where blood has characteristic absorption patterns. By focusing on 900-1100 nm where hemoglobin and glucose exhibit distinctive absorption, the device extracts blood-specific information while taking out (excluding) the overwhelming background absorption from skin, fat, muscle, and bone that occurs at other wavelengths.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent changes the detection parameter from broad-spectrum absorption to wavelength-specific absorption in the 900-1100 nm range. This parameter change allows the system to detect subtle variations in blood glucose concentration by measuring absorption at wavelengths where blood components have characteristic spectral signatures, thereby improving signal-to-noise ratio despite measuring through all body tissues.

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If multiple wavelengths are used to improve glucose detection accuracy, then measurement precision improves, but device complexity increases

Engineering Contradiction:
Improveglucose concentration accuracyVSAvoidoptical system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent applies universality by using a single broad-band light source (900-1100 nm) that can detect multiple parameters simultaneously. This wavelength range allows the device to measure glucose concentration, detect blood presence, and compensate for variations in tissue composition all with one light source and detector system, rather than requiring separate systems for each measurement.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent uses partial action by focusing on a specific wavelength subset (900-1100 nm) rather than analyzing the entire optical spectrum. This partial spectral analysis provides sufficient information for accurate glucose detection while avoiding the excessive complexity that would result from full-spectrum analysis across all wavelengths.

Inventive Principle:
Principle #16Partial or excessive action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This configuration significantly increases the light power received by detectors, enhancing the signal-to-noise ratio and allowing for more accurate determination of glucose levels without increasing device size or battery power consumption.

Implementation Method 1

an aspheric lens to increase light power and improve signal-to-noise ratios, including a processor to calculate the change in light absorption caused by blood using multiple light beams of different wavelengths and interference filters to focus and concentrate light onto a detector array

Methodology Applied
Scientific EffectLight focusing: Lens

Implementation Method 2

interference filters to focus and concentrate light onto a detector array

Methodology Applied
Scientific EffectOptical filtering: Filter (optical)

Implementation Method 3

A fundamental property of a sample, whether it is a gas, liquid or solid, is its tendency or lack of tendency to absorb or scatter light at certain wavelengths

Methodology Applied
Scientific EffectLight absorption: Absorption (EM radiation)

Data Source

PatentEP2198268B1Optical apparatus for determining a blood characteristic
Publication Date: 2022.03.16 ST LOUIS MEDICAL DEVICES INC
  • EP2198268B1 patent drawingFigure 1A
  • EP2198268B1 patent drawingFigure 1B
  • EP2198268B1 patent drawingFigure 2

AI summary

Embodiments of the invention relate to an apparatus including a light source to generate a plurality of light beams with each of the plurality of light beams having a different wavelength range. The apparatus also includes a light funnel to direct the plurality of light beams to the target area, an aperture to direct the plurality of light beams emitting from the target area to a lens, the lens configured to collect the light beams emitting from the target area. Further, the apparatus includes a detector including a plurality of light-sensing devices each configured to detect a light beam and configured to generate an output signal indicative of an intensity of light detected and a processor for determining the blood characteristic as a function of each generated output signal.